Botanix Pharmaceuticals (Botanix Pharmaceuticals) Market Cap : $288.27 Mil (As of Jun. 09, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Botanix Pharmaceuticals Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Botanix Pharmaceuticals's share price for the quarter that ended in Dec. 2023 was $0.12. Botanix Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 1,547.14 Mil. Therefore, Botanix Pharmaceuticals's market cap for the quarter that ended in Dec. 2023 was $185.66 Mil.

Botanix Pharmaceuticals's quarterly market cap increased from Dec. 2022 ($23.75 Mil) to Jun. 2023 ($78.75 Mil) and increased from Jun. 2023 ($78.75 Mil) to Dec. 2023 ($185.66 Mil).

Botanix Pharmaceuticals's annual market cap declined from Jun. 2021 ($68.12 Mil) to Jun. 2022 ($36.69 Mil) but then increased from Jun. 2022 ($36.69 Mil) to Jun. 2023 ($78.75 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Botanix Pharmaceuticals's Enterprise Value for Today is $282.49 Mil.

Botanix Pharmaceuticals Market Cap Historical Data

The historical data trend for Botanix Pharmaceuticals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Botanix Pharmaceuticals Market Cap Chart

Botanix Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Market Cap

Get a 7-Day Free Trial

29.18

68.12

36.69

78.75

Botanix Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Market Cap	Get a 7-Day Free Trial															38.83	36.69	23.75	78.75	185.66

Competitive Comparison of Botanix Pharmaceuticals's Market Cap

For the Biotechnology subindustry, Botanix Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Botanix Pharmaceuticals's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Botanix Pharmaceuticals's Market Cap distribution charts can be found below:

* The bar in red indicates where Botanix Pharmaceuticals's Market Cap falls into.

Botanix Pharmaceuticals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Botanix Pharmaceuticals's Market Cap for the fiscal year that ended in Jun. 2023 is calculated as

Market Cap (A: Jun. 2023 )	=	Share Price (A: Jun. 2023 )	*	Shares Outstanding (EOP) (A: Jun. 2023 )
	=	$0.06	*	1312.46
	=	$78.75

Botanix Pharmaceuticals's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )	=	Share Price (Q: Dec. 2023 )	*	Shares Outstanding (EOP) (Q: Dec. 2023 )
	=	$0.12	*	1547.14
	=	$185.66

Botanix Pharmaceuticals (OTCPK:BXPHF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Botanix Pharmaceuticals Market Cap Related Terms

Thank you for viewing the detailed overview of Botanix Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Botanix Pharmaceuticals (Botanix Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Botanix Pharmaceuticals Ltd (OTCPK:BXPHF) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

BOT:Australia

Address

661 Newcastle Street, D2, LEEDERVILLE, WA, AUS, 6007

Website

https://www.botanixpharma.com

Botanix Pharmaceuticals Ltd is a clinical-stage cannabinoid therapeutics company. The company's focus is the development of safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system - Permetrex for direct skin delivery of active pharmaceuticals in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1308 - Plaque Psoriasis, BTX1204 - Atopic Dermatitis, and BTX 1701 - Mild Acne. The majority of Revenue is Derived from Australia.

Botanix Pharmaceuticals (Botanix Pharmaceuticals) Headlines

From GuruFocus

Botanix | World First Human Clinical Study Shows Synthetic CBD Formula Eradicates Staphylococcus Aureus

By Business Wire Business Wire • 02-03-2021